Orion Diagnostica initiates co-operation negotiations concerning 14 persons in Oulu
(Thomson Reuters ONE) -
ORION CORPORATION PRESS RELEASE 6 APRIL 2017 at 14.00 EEST
Orion Diagnostica initiates co-operation negotiations concerning 14 persons in
Oulu
Orion Diagnostica Oy, a subsidiary of Orion Corporation focusing on diagnostic
tests, has received a notice of termination from its landlord to terminate the
lease agreement of Orion Diagnostica's premises in Oulu. For this reason, the
operations of Orion Diagnostica Oy in the current premises will end by the end
of September 2017 at the latest.
Orion Diagnostica Oy has today given a negotiation proposal, as laid down in the
Finnish Act on Co-operation within Undertakings, on reorganising operations and
possible personnel reductions in Oulu. The negotiations concern 14 employees.
Possible reorganisation of the operations may lead to transfers of employees in
Oulu, transfers of employees to other locations or to other positions in the
Orion Group, changes to the terms of employment as well as possible terminations
of employments. Should redundancies occur, the employer would, according to a
preliminary estimate, give notices during 2017.
Contact person:
Kaisa Tarkkanen, President, Orion Diagnostica Oy
tel. +358 10 426 3268
Publisher:
Orion Corporation
Communications
Orionintie 1A, FI-02200 Espoo, Finland
Homepage: www.orion.fi
Orion is a globally operating Finnish pharmaceutical company - a builder of
well-being. Orion develops, manufactures and markets human and veterinary
pharmaceuticals, active pharmaceutical ingredients and diagnostic tests. The
company is continuously developing new drugs and treatment methods. The core
therapy areas of Orion's pharmaceutical R&D are central nervous system (CNS)
disorders, oncology and respiratory for which Orion developes inhaled Easyhaler®
pulmonary drugs. Orion's net sales in 2016 amounted to EUR 1,074 million and the
company had about 3,500 employees. Orion's A and B shares are listed on Nasdaq
Helsinki. Founded in 1917, Orion celebrates its centennial anniversary in 2017.
This announcement is distributed by Nasdaq Corporate Solutions on behalf of Nasdaq Corporate Solutions clients.
The issuer of this announcement warrants that they are solely responsible for the content, accuracy and originality of the information contained therein.
Source: Orion Oyj via GlobeNewswire
Unternehmensinformation / Kurzprofil:
Datum: 06.04.2017 - 13:00 Uhr
Sprache: Deutsch
News-ID 534973
Anzahl Zeichen: 2687
contact information:
Town:
Espoo
Kategorie:
Business News
Diese Pressemitteilung wurde bisher 149 mal aufgerufen.
Die Pressemitteilung mit dem Titel:
"Orion Diagnostica initiates co-operation negotiations concerning 14 persons in Oulu"
steht unter der journalistisch-redaktionellen Verantwortung von
Orion Oyj (Nachricht senden)
Beachten Sie bitte die weiteren Informationen zum Haftungsauschluß (gemäß TMG - TeleMedianGesetz) und dem Datenschutz (gemäß der DSGVO).
